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Introduction
This study was conducted to investigate the role of
serum procalcitonin and CRP levels in determining
etiology, treatment and prognosis in COPD patients
with acute exacerbation.
Methods
Fifty-eight hospitalized COPD patients with acute exacer-
bation were included in the study between January 2008
and March 2011. The diagnosis of COPD was made
according to the GOLD guidelines. Serum CRP and pro-
calcitonin (PCT) levels in the first day of hospitalization
and then one month later (in a stable period) were stu-
died from all COPD patients. Patients were classified into
4 groups according to the severity of disease and divided
into 2 groups according to the PCT levels (< 0.2 ng/dl
and > 0.2 ng/dl).
Results
Four (7%) patients were female and 54 (93%) were male.
The mean age was 68.1 ± 10.1. Pathogenic bacterial
growth was detected in 16 sputum or bronchial lavage
samples. MRSA was found in 3 samples, P. aeruginosa
in 3, S. maltophilia in 3, and Enterobacter species was
detected in 2 samples. Chlamydia pneumoniae serology
was positive in 16 (29%) patients. M. pneumoniae was
positive in 8 (15%) patients. The rate of M. pneumoniae
was highest (40%) in the severe exacerbation group.
PCT level was significantly higher in the Chlamydia
positive group (40% vs. 22%). The mean CRP level of
COPD patients was 6.7 mg/l in acute attack, and
2.0 mg/l in the stable period. The mean PCT level was
0.50 ng/l in acute attack, and 0.09 ng/l in the stable per-
iod. Serum PCT level was found as 0.44 ng/l in severe
COPD group, and 0.2 ng/ml in the others (p = 0.02). 27
patients with acute exacerbation of COPD were diag-
nosed with sepsis. Six patients in the study group died.
Mortality rate was higher in high PCT group (13.3% vs. 2.5%).
Conclusions
PCT level can help for determining acute attack and
etiology in COPD patients.
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